The effect of high oral loading dose of cholecalciferol in non-alcoholic fatty liver disease patients. A randomized placebo controlled trial

The effect of high oral loading dose of cholecalciferol in non-alcoholic fatty liver disease patients. A randomized placebo controlled trial

Background and Aim: Non-alcoholic fatty liver (NAFLD) is one of the most common progressive metabolic disorders worldwide. There are increasing scientific interests nowadays for the association between vitamin D status and Non-alcoholic fatty liver. Earlier studies have revealed that vitamin D defic...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Amal Ahmed Mohamed, Ahmed Abdel Halim, Sahar Mohamed, Seham Mohamed Mahmoud, Eman Mohamed Bahgat Eldemiry, Rasha Sobh Mohamed, Mahmoud Maamoun Shaheen, Gina G. Naguib, Nashwa M. Muharram, Mona G. Khalil, Salma Saed, Randa Ibrahim, Ahmed Salah Seif, Noha Kamal, Karima Nasraldin, Ali Elsaid Abdelrahman, Radwa El Borolossy
Formáid: Alt
Teanga:English
Foilsithe / Cruthaithe: Frontiers Media S.A. 2023-03-01
Sraith:Frontiers in Pharmacology
Ábhair:
non-alcoholic fatty liver
Cholecalciferol
Steatosis
lipid profile
hsCRP
Rochtain ar líne:https://www.frontiersin.org/articles/10.3389/fphar.2023.1149967/full

Ar líne

https://www.frontiersin.org/articles/10.3389/fphar.2023.1149967/full

Míreanna comhchosúla